Home Investment Portfolio Sunnybrook Research Institute (Glypican-3, Dr. J. Filmus) Innovation Type: Diagnostics Cancer Type: Liver Funding Stage: Proof of Concept Fund: Compass Rose Glypican-3: a novel marker for the early diagnosis of hepatocellular carcinoma Related news There are currently no news items related to this portfolio company. CONNECT WITH FACIT Learn more about how we are driving made-in-Ontario oncology innovations reach the market. Please note that only Ontario-based innovations related to oncology and cancer care are eligible for FACIT's investment and commercialization support. Name: Email: Message:
